Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Mar 20, 2026 (7 months ago)

exchange select (Menthol Flavor Cough Drop)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Cause type: Other

Recalls whose stated reason does not fall into the categories above. See the recall's own reason text for the specifics. All other recalls.

What was recalled

exchange select, Menthol- Cough Suppressant Oral Anesthetic, Cough Drops, Menthol Flavor, 30-count bag, Manufactured for Your Military Exchanges By: Medical Group Care, LLC, 1035 Collier Center Way, STE 5, Naples, FL, Made in China, NDC: 83698-581-30, UPC: 614299398887.

Affected NDC 83698-0581-30

Compare with the code on your package — it is the most precise check available.

Drug: Menthol

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Menthol Flavor Cough Drop
NDC 83698-0581
MENTHOL 5.4 mg/1 Lozenge
Oral
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. OTC
Recalling firm
Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
Origin
N/A, China
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0457-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Menthol recalls

See all
Class II · Moderate risk

Zicam

CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing

Ongoing Microbial contamination Church & Dwight Co., Inc. D-0790-2026

Other recalls by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

All 2026 recalls
Class II · Moderate risk

QC Quality Choice

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Ongoing Other Xiamen Kang Zhongyuan Biotechnology Co., Ltd. D-0470-2026
Class II · Moderate risk

QC Quality Choice

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Ongoing Other Xiamen Kang Zhongyuan Biotechnology Co., Ltd. D-0469-2026
Class II · Moderate risk

QC Quality Choice

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Ongoing Other Xiamen Kang Zhongyuan Biotechnology Co., Ltd. D-0468-2026
Class II · Moderate risk

QC Quality Choice

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Ongoing Other Xiamen Kang Zhongyuan Biotechnology Co., Ltd. D-0467-2026